{"created":"2021-03-01T06:25:48.264696+00:00","id":20815,"links":{},"metadata":{"_buckets":{"deposit":"53d2e4c0-e28e-40a1-af42-91697b2613fb"},"_deposit":{"id":"20815","owners":[],"pid":{"revision_id":0,"type":"depid","value":"20815"},"status":"published"},"_oai":{"id":"oai:niigata-u.repo.nii.ac.jp:00020815","sets":["453:456","471:537:538:1171"]},"item_7_alternative_title_1":{"attribute_name":"その他のタイトル","attribute_value_mlt":[{"subitem_alternative_title":"Evaluation of Molecular Markers of Blood Coagulation and Fibrinolysis in Patients with Renal Diseases"}]},"item_7_biblio_info_6":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"1992-08","bibliographicIssueDateType":"Issued"},"bibliographicIssueNumber":"8","bibliographicPageEnd":"743","bibliographicPageStart":"739","bibliographicVolumeNumber":"106","bibliographic_titles":[{"bibliographic_title":"新潟医学会雑誌"},{"bibliographic_title":"新潟医学会雑誌","bibliographic_titleLang":"en"}]}]},"item_7_description_4":{"attribute_name":"抄録","attribute_value_mlt":[{"subitem_description":"Thrombosis is one of the main complications in patients with renal diseases, especially nephrotic syndrome. Previously, urinary FDP or fibrinopeptide A has been used as a thrombotic markers in these patients. I measured plasma levels of various coagulation and fibrinolytic markers in 32 patients with renal diseases. Plasma concentration of plasmin-α_2-plasmin inhibitor complex (PIC), thrombin-antithrombin III complex (TAT) and D-dimer were significantly elevated in patients with renal diseases as compared to healty subjects；0.85±0.70 vs 0.24±0.13 μg/ml, 2.94±1.11 vs 1.86±0.47 μg/1,185.58±269.41 vs 30±14 ng/ml, respectevely. Plasma PIC and TAT levels were relatively high in patients with rapidly progressive glomerular nephntis (RPGN) and lupus glomerular nephritis (lupus GN). These findings indicate that these molecular markers were useful for the assessment of hypercoagulable and/or hyperfibrinolytic renal diseases.","subitem_description_type":"Abstract"}]},"item_7_full_name_3":{"attribute_name":"著者別名","attribute_value_mlt":[{"nameIdentifiers":[{"nameIdentifier":"128097","nameIdentifierScheme":"WEKO"}],"names":[{"name":"Wada, Ken"}]}]},"item_7_publisher_7":{"attribute_name":"出版者","attribute_value_mlt":[{"subitem_publisher":"新潟医学会"}]},"item_7_select_19":{"attribute_name":"著者版フラグ","attribute_value_mlt":[{"subitem_select_item":"publisher"}]},"item_7_source_id_11":{"attribute_name":"書誌レコードID","attribute_value_mlt":[{"subitem_source_identifier":"AN00182415","subitem_source_identifier_type":"NCID"}]},"item_7_source_id_9":{"attribute_name":"ISSN","attribute_value_mlt":[{"subitem_source_identifier":"00290440","subitem_source_identifier_type":"ISSN"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"和田, 研"}],"nameIdentifiers":[{"nameIdentifier":"128096","nameIdentifierScheme":"WEKO"}]}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2019-08-16"}],"displaytype":"detail","filename":"106(08)_739-743.pdf","filesize":[{"value":"765.1 kB"}],"format":"application/pdf","licensetype":"license_note","mimetype":"application/pdf","url":{"label":"106(08)_739-743.pdf","url":"https://niigata-u.repo.nii.ac.jp/record/20815/files/106(08)_739-743.pdf"},"version_id":"2f2b4f3a-c943-45e6-b2e3-99c7f1760f59"}]},"item_keyword":{"attribute_name":"キーワード","attribute_value_mlt":[{"subitem_subject":"renal diseases","subitem_subject_scheme":"Other"},{"subitem_subject":"molecular marker","subitem_subject_scheme":"Other"},{"subitem_subject":"thrombin-antithrombin III complex","subitem_subject_scheme":"Other"},{"subitem_subject":"plasmin-α_2-plasnin inhibitor complex","subitem_subject_scheme":"Other"},{"subitem_subject":"D-dimer","subitem_subject_scheme":"Other"},{"subitem_subject":"腎疾患","subitem_subject_scheme":"Other"},{"subitem_subject":"分子マーカー","subitem_subject_scheme":"Other"},{"subitem_subject":"トロンビン-アンチトロンビンIII複合体","subitem_subject_scheme":"Other"},{"subitem_subject":"プラスミンα_2プラスミンインヒビター複合体","subitem_subject_scheme":"Other"},{"subitem_subject":"Dダイマー","subitem_subject_scheme":"Other"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"jpn"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"departmental bulletin paper","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_title":"各種腎疾患における血液凝固線溶分子マーカーの検討","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"各種腎疾患における血液凝固線溶分子マーカーの検討"},{"subitem_title":"各種腎疾患における血液凝固線溶分子マーカーの検討","subitem_title_language":"en"}]},"item_type_id":"7","owner":"1","path":["456","1171"],"pubdate":{"attribute_name":"公開日","attribute_value":"2016-03-18"},"publish_date":"2016-03-18","publish_status":"0","recid":"20815","relation_version_is_last":true,"title":["各種腎疾患における血液凝固線溶分子マーカーの検討"],"weko_creator_id":"1","weko_shared_id":null},"updated":"2022-12-15T03:51:31.338789+00:00"}